The hybrid ablation treatment developed at Maastricht UMC+ leads to better results in persistent atrial fibrillation than the standard treatment, catheter ablation.

Someone with diabetes has an increased risk of depression, but may be able to limit it by addressing risk factors such as unhealthy diet and high blood pressure. This has emerged from research by scientists at Maastricht UMC+ who analyzed data from nearly 78,000 people.

For some of the patients with serious cardiac arrhythmias (ventricular tachycardia, VT), current treatments, such as medication or ablation, do not offer a solution. Researchers from CARIM and Maastro, in collaboration with 30 partner organizations in 8 European countries, will therefore conduct research into a new treatment method: non-invasive radioablation.

The Dutch Heart Foundation has awarded a Dr. E. Dekker postdoc grant to Dr Magdi Nagy (Dept. of Biochemistry).

Earlier this month, dr. ir. Rob Holtackers (Department of Radiology & Nuclear Medicine) won the Kootstra Talent Fellowship with his proposed study 'lnterventional cardiac MRI: a new strategy for improved diagnostics and treatment of cardiac arrhythmias'.

What exactly are the underlying mechanisms that lead to the development of atrial fibrillation? And what causes someone to suffer more from the consequences of this heart rhythm disorder? The EmbRACE network will investigate this under the supervision Prof. Michiel Rienstra of the University Medical Center Groningen and Prof. Uli Schotten of CARIM.

Three research teams coordinated by CARIM researchers are starting their projects funded with money from the Open Competition of grant provider ZonMw. Each research team will receive €750,000 on average.

Matthijs Cluitmans (Dept. of Cardiology) received the WCN Research Prize 2022 during the annual WCN congress in Amsterdam.

Dr.ir. Rob Holtackers (Dept. of Radiology) and his iCMR team have won the Team Science Award from the Dutch Research Council (NWO).